Immunotherapy represents a groundbreaking approach in the battle against cancer, leveraging the body's own immune system to combat the disease. Sierra Nevada Cancer Center (SNCC) is at the forefront of this innovative treatment, offering cancer vaccines and other immunotherapies that promise a more targeted and effective fight against various forms of cancer. With a focus on enhancing the immune system's natural capabilities, SNCC's treatments are reshaping the landscape of cancer care.
The immune system is our body's natural defense mechanism, designed to detect and eliminate harmful pathogens and abnormal cells. While it can recognize and attack cancer cells to some extent, its ability to combat cancer independently is limited. This is where immunotherapy steps in, aiming to amplify the immune system's cancer-fighting potential.
Dr. Jorge Perez of Sierra Nevada Cancer Center explains that immunotherapy is a dynamic and evolving cancer treatment option. It aims to boost the body's defenses to either halt or reverse the progression of cancer. Immunotherapy has shown promise in treating a range of cancers, including melanoma, breast, prostate, and lung cancer, which are among the most prevalent and deadly forms of the disease.
According to the American Cancer Society, melanoma accounts for only about 1% of skin cancers but causes a large majority of skin cancer deaths. Breast cancer is the most commonly diagnosed cancer among American women, aside from skin cancers, with an estimated 287,850 new cases expected in 2023. Prostate cancer is the most common cancer in American men, with about 268,490 new cases anticipated in 2023. Lung cancer remains the leading cause of cancer death, with more than 130,000 deaths projected in the United States for 2023.
Traditional treatments for these cancers typically include surgery, radiation therapy, chemotherapy, and targeted therapy. However, immunotherapy can be used alongside these methods, often improving clinical outcomes for patients.
Immunotherapy encompasses several approaches, including:
Cancer vaccines come in two forms: preventive and therapeutic. Preventive vaccines, like the HPV vaccine, are designed to avert cancers caused by viruses. The HPV vaccine has been effective in reducing the risk of cervical, anal, and throat cancers linked to the human papillomavirus. On the other hand, therapeutic vaccines, such as Sipuleucel-T (Provenge®), are used to treat existing cancers by boosting the immune system's response. Provenge® is FDA-approved for advanced prostate cancer and has been shown to extend patient survival.
Monoclonal antibodies are synthetic versions of immune system proteins that can be precisely directed to attack cancer cells. The FDA has approved numerous mAbs for cancer treatment, which can be categorized as either 'naked', without attached drugs, or 'conjugated', linked to chemotherapy drugs or radioactive particles. Adoptive T cell therapy is a related approach where T cells are extracted, modified, and reintroduced to the patient to enhance the immune response against cancer.
Cancer cells often exploit immune checkpoints to avoid detection. Checkpoint inhibitors work by unlocking these immune cells, allowing them to recognize and destroy cancer cells. These inhibitors have been particularly successful in treating advanced melanoma, often leading to tumor shrinkage and prolonged patient survival.
While immunotherapy cannot cure all cancers, it has significantly improved the outlook for many patients. As our understanding of the immune system deepens, treatments continue to advance. Some immunotherapies aim to generally boost the immune system, while others train it to target cancer cells specifically.
The potential of immunotherapy is vast, and ongoing research is uncovering new applications and improving existing treatments. For instance, a study published in the New England Journal of Medicine showed that combining immunotherapy with chemotherapy extended survival for lung cancer patients without worsening quality of life.
Sierra Nevada Cancer Center remains committed to providing patients with the latest and most effective immunotherapy options. For those facing cancer, these treatments offer a beacon of hope, harnessing the power of the immune system to fight back against the disease. To learn more about immunotherapy and cancer vaccines, visit Sierra Nevada Cancer Center.
Cancer Treatment Options Abound for Cancer Patients
As one of the leading cancer treatment centers in Nevada, Sierra Nevada Cancer Center offers comprehensive cancer care.
Sierra Nevada Cancer Center Offers Lung Cancer Treatment in Your Hometown
Sierra Nevada Cancer Center has served the Northern Nevada area for many years to provide the community with the best cancer-fighting technology available. The treatment center pridesitself on staying at the forefront of cancer research and is committed to offering patients the most leading-edge treatments available.
Are Breast Cancer Vaccines The New Chemotherapy
Chemotherapy for breast cancer is one of today’s most common treatments. However, tomorrow’s therapies are giving patients and breast cancer centers new hope for a better, gentler cure, thanks to promising studies on breast cancer vaccines.
